- Home
- HYFM vs BOLT Comparison
HYFM vs BOLT Comparison
Compare HYFM & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HYFM
- BOLT
- Stock Information
- Founded
- HYFM 1977
- BOLT 2015
- Country
- HYFM United States
- BOLT United States
- Employees
- HYFM N/A
- BOLT N/A
- Industry
- HYFM Industrial Machinery/Components
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- HYFM Industrials
- BOLT Health Care
- Exchange
- HYFM Nasdaq
- BOLT Nasdaq
- Market Cap
- HYFM 16.0M
- BOLT 16.8M
- IPO Year
- HYFM 2020
- BOLT 2021
- Fundamental
- Price
- HYFM $3.57
- BOLT $5.69
- Analyst Decision
- HYFM Hold
- BOLT Buy
- Analyst Count
- HYFM 2
- BOLT 3
- Target Price
- HYFM $7.00
- BOLT $50.00
- AVG Volume (30 Days)
- HYFM 10.6K
- BOLT 23.5K
- Earning Date
- HYFM 08-07-2025
- BOLT 08-12-2025
- Dividend Yield
- HYFM N/A
- BOLT N/A
- EPS Growth
- HYFM N/A
- BOLT N/A
- EPS
- HYFM N/A
- BOLT N/A
- Revenue
- HYFM $176,650,000.00
- BOLT $3,638,000.00
- Revenue This Year
- HYFM $5.45
- BOLT N/A
- Revenue Next Year
- HYFM $5.33
- BOLT $24.14
- P/E Ratio
- HYFM N/A
- BOLT N/A
- Revenue Growth
- HYFM N/A
- BOLT N/A
- 52 Week Low
- HYFM $1.50
- BOLT $5.20
- 52 Week High
- HYFM $8.55
- BOLT $15.60
- Technical
- Relative Strength Index (RSI)
- HYFM 50.79
- BOLT 42.69
- Support Level
- HYFM $3.50
- BOLT $5.36
- Resistance Level
- HYFM $3.83
- BOLT $6.07
- Average True Range (ATR)
- HYFM 0.36
- BOLT 0.44
- MACD
- HYFM -0.01
- BOLT -0.01
- Stochastic Oscillator
- HYFM 36.28
- BOLT 25.58
About HYFM Hydrofarm Holdings Group Inc.
Hydrofarm Holdings Group Inc is a distributor and manufacturer of agriculture equipment and supplies. Some of its products includes lighting solutions, growing media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies sold under proprietary, exclusive/preferred brands, or non-exclusive/distributed brands. The business is organized into two operating segments, the U.S. and Canada.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.